MRI study to prepare for adaptive MRI-guided radiation of prostate carcinoma.

• Conditions: Prostate cancer; prostate carcinoma; 10038597

• Registration Number: NL-OMON49848
• Lead Sponsor: Radiotherapiegroep

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

Low to intermediate risk prostate carcinoma; scheduled for external beam
radiation therapy; meet all MRI safety criteria; written informed consent; over
18 years of age

Exclusion Criteria

Transurethral resection of the prostate (TURP) in the last 3 months; hip
prosthesis

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Dose parameters D2cc of the bladder and prostate, which are an indication for<br /><br>toxicity.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable.</p><br>